Eric Lefkofsky, the founder of Groupon is one of Chicago’s more well-known “techie” who is onto a new project that he is investing in and spending the time in its development. The new project is called Tempus Health, Inc. and it is a bonafide serious cancer research facility.
The purpose of Tempus is to help healthcare professionals and doctors make important decisions in regard to treating cancer. The science revolves around decisions that are data-driven based on the genetic code of the individual. It utilizes cutting-edge analysis of genomic sequencing so that it can be better understood how tumors grow and develop and more information click here.
Large amounts of data have already been accumulated and studied over time and the statistics have been transformed into algorithms to be studied and applied to actual cases. The bottom line and goal are to be able to provide more precise diagnoses and personalize the treatment more effectively and learn more about Eric Lefkofsky.
Lefkofsky and his wife have given to cancer research in the past to such agencies as the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and to the Immunotherapy for Gastric Cancer Research at Stanford University. Lefkofsky is also a trustee of the well-known Lurie Children’s Hospital of Chicago.
Lefkofsky has long been an advocate of artificial intelligence becoming one of the driving forces behind solving some of the medicine’s most difficult challenges, and he believes that Tempus is going to be a major force behind such a movement and its website.
He believes that big steps are soon to be taken in medicine as we begin to understand more fully the intricacies that it will take to tame a disease such as cancer. He points out that in 2003 when the first genome was sequenced, it cost $100,000 to get the job done. Today we can accomplish the same feat for only $5.000 which is a 20,000 percent decrease in the cost. And, it won’t b e long until it only costs a few hundred dollars and Eric’s lacrosse camp.
By being able to create a molecular map for each individual person, we will be able to treat diseases on the cellular level. This opens the door to amazing treatment protocols and longevity possibilities.